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Introduction
Testicular germ cell tumours (TGCTs) are among the
most frequent solid malignant tumours in 15- to
39-year-old men (Ferlay et al., 2010). Based on epidemi-
ology, clinical presentation, phenotypic characterization,
chromosomal constitution and genomic imprinting,
TGCTs are classified into three groups (Oosterhuis &
Looijenga, 2005). Type I comprises the teratomas and
yolk-sac tumours of newborns and infants; type II com-
prises the seminomatous and non-seminomatous tumours
of adolescents and young adults; and type III comprises
the spermatocytic seminomas of elderly people. It is gen-
erally accepted that type II TGCTs arise from a common
pre-invasive lesion, known as in situ carcinoma (CIS)
(Skakkebaek, 1972; Kristensen et al., 2008). Currently,
various non-seminomatous cell lines have been estab-
lished, but only one (i.e. TCam-2) (Mizuno et al., 1993;
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Summary
The glial cell line–derived neurotrophic factor (GDNF) has multiple functions
that promote cell survival, proliferation and migration in different cell types.
The experimental over-expression of GDNF in mouse testis leads to infertility
and promotes seminomatous germ cell tumours in older animals, which sug-
gests that deregulation of the GDNF pathway may be implicated in germ cell
carcinogenesis. GDNF activates downstream pathways upon binding to its spe-
cific co-receptor GDNF family receptor-a 1 (GFRA1). This complex then inter-
acts with Ret and other co-receptors to activate several intracellular signalling
cascades. To explore the involvement of the GDNF pathway in the onset and
progression of testicular germ cell tumours, we analysed GFRA1 and Ret
expression patterns in seminoma samples. We demonstrated, via immunohisto-
chemistry, that GFRA1, but not Ret, is over-expressed in in situ carcinoma
(CIS) and in intratubular and invasive seminoma cells compared with normal
human germ cells. Functional analysis of the GDNF biological activity was per-
formed on TCam-2 seminoma cell line. Reverse transcription-PCR (RT-PCR)
and immunohistochemical analyses demonstrate that TCam-2 cells express
both GFRA1 and Ret mRNA, but only GFRA1 was detected at the protein
level. In TCam-2 cells, although GDNF is not mitogenic, it is able to induce
migration, as demonstrated by a Boyden chamber assay, possibly through the
Src and MEK pathways. Moreover, GDNF promotes invasive behaviour, an
effect dependent on pericellular protease activity, possibly through the activity
of matrix metalloproteinases. GFRA1 over-expression in CIS and seminoma
cells, along with the functional analyses in TCam-2 cells, suggests an
involvement of the GDNF pathway in the progression of testicular germ cell
cancer.
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Eckert et al., 2008; de Jong et al., 2008) has been estab-
lished from seminoma, although they constitute more
than 50% of all TGCTs (Ulbright, 2005).
Glial cell line–derived neurotrophic factor (GDNF) was
first identified through its activity on midbrain dopami-
nergic neurons (Lin et al., 1993). Subsequently, GDNF
has been shown to have pleiotropic functions, promoting
neuroprotection (Beck et al., 1995; Tomac et al., 1995),
kidney development and enteric innervations (Moore
et al., 1996; Pichel et al., 1996; Sanchez et al., 1996).
GDNF exerts its effect on target cells by binding to a gly-
cosyl phosphatidylinositol–linked GDNF family receptor-a
1 (GFRA1) (Airaksinen & Saarma, 2002). This binding
recruits the receptor tyrosine kinase Ret to form a multi-
subunit signalling complex of GDNF ⁄GFRA1 ⁄Ret. In
addition, GDNF binding is transduced by GFRA1 in a
Ret-independent fashion (Airaksinen & Saarma, 2002;
Sariola & Saarma, 2003). Mice with a homozygous dele-
tion of GDNF die shortly after birth because of severe
defects in renal differentiation and the absence of an
enteric nervous system (Moore et al., 1996; Pichel et al.,
1996; Sanchez et al., 1996). GDNF is important for male
fertility because it plays a central role in spermatogonial
stem cell self-renewal and proliferation (Hofmann, 2008).
Reduced GDNF dosage in heterozygous GDNF+ ⁄)
animals leads to an excessive differentiation of spermato-
gonia and finally to an exclusive Sertoli cell phenotype,
whereas over-expression of GDNF leads to a block of
stem cell differentiation (Meng et al., 2000). GDNF is also
an essential factor in the maintenance and expansion of
in vitro spermatogonial stem cells in different mammals
(Kanatsu-Shinohara et al., 2003, 2008; Kubota et al.,
2004; Wu et al., 2009). In rodent testis, GDNF is pro-
duced by the Sertoli cells, the somatic cells supporting
germ cell development (Tadokoro et al., 2002). However,
in human testis, GDNF is produced by Sertoli cells and
by cells of the peritubular wall of the seminiferous tubules
(Spinnler et al., 2010). Less is known concerning the role
of GDNF in cancer. GDNF promotes cell migration ⁄
chemotaxis and the invasion of pancreatic (Okada et al.,
1999; Veit et al., 2004), chondrosarcoma (Su et al., 2009)
and glioma cell lines (Song & Moon, 2006). Interestingly,
older transgenic mice that over-express GDNF frequently
develop testicular tumours with the morphology and
immunohistochemical profile (placental-like alkaline
phosphatase positive) of classical human seminomas
(Meng et al., 2001). Invasion of undifferentiated sperma-
togonia into the interstitium occurs after a year of age
(Meng et al., 2000). More recently, a link between the
doublesex and mab-3 related transcription factor 1
(DMRT1) tumour-suppressor protein and the deregula-
tion of the GDNF signalling pathway has been found in
TGCTs. DMRT1 is a transcription factor that has been
implicated in testicular development. The loss of Dmrt1
in foetal testis induces the reduction of Ret expression
and increased teratoma formation. However, increased
DMRT1 expression is associated with increased GDNF
signalling and spermatocytic seminoma (Krentz et al.,
2009). These observations suggest that deregulation of the
GDNF pathway might be implicated in germ cell carcino-
genesis even if the molecular alterations involved are not
known (Meng et al., 2001).
We undertook this study to determine the potential
role of the GDNF pathway in the onset and progression
of human seminomas. For this purpose, we first analysed
the expression pattern of GFRA1 and Ret, the two major
co-receptors for GDNF, in CIS and seminoma samples.
Apart from a single study (Viglietto et al., 2000), there is
scant information on the expression of GDNF and its
co-receptors in human TGCTs. We report that GFRA1
was expressed more extensively in CIS cells and invasive
seminoma compared with normal testis, via immunohis-
tochemical analysis. Thus, the potential function of the
activation of the GDNF pathway in seminoma cells was
investigated using the TCam-2 human seminoma cell line
as a model system.
Materials and methods
Tumour samples
Surgical samples were obtained from 10 patients with
testicular seminoma (mean age: 35.5 years, range:
23–50 years). The specimens were fixed in 10% formalin-
buffered solution and paraffin embedded. Morphological
analysis of haematoxylin-eosin stained sections indicated
that tumour samples contained variable amounts of semi-
niferous tubules with qualitatively normal spermatogene-
sis (8 ⁄ 10), atrophic seminiferous tubules (8 ⁄ 10),
seminiferous tubules with pre-invasive CIS cells (8 ⁄ 10)
and invasive seminoma cells (10 ⁄ 10). Informed written
consent was obtained from all subjects; the study was
approved by the Sapienza University of Rome Ethics
Committee.
Immunohistochemistry (IHC)
Immunohistochemistry was performed as described
(Muciaccia et al., 2010). Briefly, 3 lm thick paraffin tissue
sections were serially collected and mounted into poly-
lysine-coated slides. Deparaffinized and rehydrated sec-
tions were subjected to an antigen retrieval procedure,
that is heating in a microwave oven (800 W) in 10 mm
sodium citrate buffer (pH 6.0) for 10 min and incubated
with primary antibodies diluted in phosphate buffered
saline (PBS) (1 : 20 anti-human monoclonal RET, 1 : 100
anti-human CD34, anti-human inhibin and anti-PLAP
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from Novocastra, Milan, Italy; 1 : 200 anti-human
GFRA1 from R&D Systems, Milan, Italy; 1 : 400 anti-
human CD117 from Dako, Milan, Italy). The sections
were then processed using the avidin-biotin peroxidase
complex (ABC) procedure, according to the manufac-
turer’s instructions (UltraTek HRP Anti-Polyvalent Kit;
ScyTek Laboratories, Rome, Italy). Negative controls were
performed by omitting the primary antibodies (data not
shown). Peroxidase activity was revealed using 3,3-diam-
inobenzidine tetrahydrochloride (Roche, Milan, Italy),
and the nuclei were counterstained using haematoxylin
solution. For IHC of the TCam-2 cells, the cells were har-
vested, collected by centrifugation, fixed in 4% parafor-
maldehyde at 4 C for 10 min and paraffin-embedded.
Paraffin sections, 5 lm thick, were processed as described
above for tissue sections. Negative controls were per-
formed by omitting the primary antibodies.
TCam-2 cell cultures
The TCam-2 human cell line was derived in 1993 from a
primary testicular tumour sample of pure classical semino-
ma (Mizuno et al., 1993). TCam-2 cell line is the only vali-
dated seminoma cell line (Eckert et al., 2008; de Jong et al.,
2008). TCam-2 cells were cultured as described in RPMI
1640 (Lonza, Treviglio, Italy) supplemented with 10% foe-
tal bovine serum (Lonza) and penicillin ⁄ streptomycin (In-
vitrogen, Monza, Italy) at 37 C in a humidified
atmosphere with 5% carbon dioxide (Goddard et al.,
2007). To test the effect of GDNF on cell proliferation and
survival, TCam-2 cells were maintained for 16 h under
serum-free conditions and then treated in the presence or
absence of 100 ng ⁄mL GDNF (R&D Systems) or 10% (v ⁄ v)
foetal bovine serum. After 24, 48 and 72 h, the cells were
trypsinized, harvested and counted. Dead cells were evalu-
ated using trypan blue exclusion staining. To test the effect
of GDNF on cell cycle entry, the cells were maintained for
16 h under serum-free conditions and then cultured in the
absence or in the presence of 100 ng ⁄mL GDNF or 10%
foetal bovine serum as positive controls for 12, 24 and
48 h. The cells were recovered, fixed overnight in 50%
EtOH at 4 C and stained with a propidium iodide ⁄RNase
solution (50 lg ⁄mL and 100 U ⁄mL) for at least 3 h. The
cell suspensions were analysed with a Beckman Coulter
Epics XL Flow Cytometer. To test for gelatinolytic activity,
TCam-2 cell conditioned media were collected after 48 h,
and the cells were lysed in 0.5% Triton X-100 in 0.1 m
Tris–HCl, pH 8.1 (Catizone et al., 2010).
Reverse transcription-PCR analysis
The cells were harvested and total RNA was extracted
with a phenol-chloroform extraction (TRIreagent; Sigma-
Aldrich, Milan, Italy). One microgram of total RNA per
sample was used for cDNA synthesis with random hexa-
mers and Transcriptor reverse transcriptase (Roche). In
control samples, reverse transcriptase was omitted to
monitor genomic DNA contaminations. PCR was per-
formed in a volume of 25 lL containing 2 lL cDNA,
50 lm KCl, 10 mm Tris–HCl (pH 8.3), 1.5 mm MgCl,
50 pmol of each amplification primer, 200 mm dNTPs
and 0.5 U Taq DNA polymerase (Roche). The primers
and PCR details are described in Table S1. The PCR
products were fractionated by 1.8% agarose gel electro-
phoresis and visualized by ethidium bromide staining.
Experiments were performed three times, using different
RNA preparations.
Boyden chamber assays
The cells were assayed for their ability to migrate through
a polycarbonate filter (pore size, 8 lm; Whatman Interna-
tional, Maidstone, UK) using Boyden chambers (Neuro-
Probe, Gaithersburg, MD, USA). The cells (5 · 104 ⁄well)
were added to the upper chamber, and GDNF, 15 lg ⁄mL
anti-GDNF antibody (R&D Systems), CXCL12 (SDF-1
from Peproteck, London, UK), 15 lg ⁄mL isotype control
antibody (R&D Systems) or FBS (control wells) were
added alone or in combination in the lower chamber. To
analyse the GDNF-triggered pathways, 10 lm U0126
(MEK inhibitor), 10 lm or 15 lm LY294002 (PI3K inhib-
itor), 10 lm PP-2 (Src-inhibitor) were added to both the
upper and bottom chambers. All inhibitors were dissolved
in dimethyl sulphoxide (DMSO) and subsequently diluted
in the medium. The various concentration of inhibitors
used did not affect cell viability as assessed by FACS anal-
ysis of propidium iodide stained cells (data not shown).
The chambers were incubated for 5 h at 37 C. The cells
were assayed for their ability to invade through filters
(8 lm) coated with Matrigel Basement Membrane Matrix,
Growth Factor Reduced (BD Biosciences, Buccinasco,
Italy) using Boyden chambers. The cells (5 · 104 ⁄well)
were added to the upper chamber, and GDNF or CXCL12
was added to the lower chamber. GDNF and CXCL12
were dissolved in PBS containing 0.1% BSA, and subse-
quently diluted in the medium. To obtain pericellular
protease inhibition, a cocktail of 250 lm E64, 2 lm
leupeptin, 100 lm pepstatin A, 2.2 lm aprotinin and
50 lm GM6001, termed the protease inhibitor mix (prot.
inh. mix) was prepared as previously described and added
to both the upper and bottom chambers (Carragher et al.,
2006). E64, pepstatin A and GM6001 were dissolved in
DMSO, leupeptin and aprotinin were dissolved in water.
All inhibitors were subsequently diluted in the medium.
Invasion was allowed to proceed for 24 or 48 h at 37 C
in a humidified atmosphere with 5% carbon dioxide, at
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which time filters were fixed and stained. The cells from
the upper side of the filter were carefully removed using a
cotton swab. The cells that had migrated or invaded to
the lower side of the filters were quantified by bright-field
microscopy using a 40· objective, and the average num-
ber of cells per field was calculated. Data are expressed as
a migration index and calculated as the fold increase over
the control. The control cells were either in serum-free
RPMI 1640 containing 0.1% BSA or in serum-free RPMI
1640 containing 0.1% BSA and DMSO. The results are
reported as the means ± standard error.
Gelatin zymography for matrix metalloproteinases
(MMPs) detection
Gelatinolytic activity of the TCam-2 conditioned media
and cell extracts were assayed as previously described
(Catizone et al., 2010). Briefly, 20 lL aliquots of condi-
tioned media and cell extracts were fractionated by 10%
SDS-polyacrylamide gel electrophoresis in the presence of
0.1% gelatin under non-reducing conditions. Following
electrophoresis, the gels were washed twice in 2.5% Triton
X-100 for 30 min at room temperature to remove SDS.
The gels were incubated at 37 C overnight in substrate
buffer, stained with 0.5% Coomassie Brilliant Blue R250
and destained in 30% methanol and 10% glacial acetic
acid (vol ⁄ vol).
Statistical analysis
All quantitative data are presented as the mean ± standard
error of the mean (SEM). Data were analysed for significant
differences between different subsets of migrated or invad-
ing cells using a one-way analysis of variance (anova)
followed by a post hoc Dunnet test. The significance level
was fixed at a = 0.05.
Results
GFRA1 is over-expressed in CIS and invasive seminoma
cells
Investigation of the expression patterns of GFRA1 and
Ret was performed by IHC on ten different testicular
seminoma samples (Fig. 1). Adjacent serial sections were
stained with antibodies against c-Kit (CD117) and PLAP,
two diagnostic markers routinely used to identify CIS and
seminoma cells, and with anti-CD34 to detect endothelial
cells (Figure S1). In seminiferous tubules displaying quali-
tative normal spermatogenesis near a CIS lesion, GFRA1
expression was detected, as previously described, in sub-
sets of dark and pale type A spermatogonia (Grisanti
et al., 2009) and in interstitial Leydig cells (Davidoff
et al., 2001) (Fig. 1A). Compared with preserved testicular
parenchyma, GFRA1 expression was up-regulated in both
CIS and intratubular seminoma cells, whereas expression
levels varied from moderate to strong in invasive semino-
ma cells (Fig. 1A). In preserved testicular parenchyma,
Ret expression was not detected in seminiferous tubules,
whereas it was clearly detected in interstitial tissue, possi-
bly in the Leydig cell lineage (Fig. 1B). In some instances,
a strong Ret expression was detected in Sertoli cells of
atrophic seminiferous tubules, with a thickened peritubu-
lar wall and lack of germ cells, as well as in Sertoli cell
cytoplasm of seminiferous tubules containing pre-invasive
CIS cells. Finally, in invasive seminoma lesions, no Ret
expression was detected in seminoma cells, whereas Ret-
positive staining was detected in both endothelial cells
(identified morphologically and by CD34 staining) and in
cell clusters, possibly endothelial ⁄pericyte precursors,
located in perivascular areas (Fig. 1B).
The TCam-2 seminoma cell line expresses the
co-receptors for GDNF
Because CIS and seminoma cells highly express the GDNF
co-receptor GFRA1, we tested the hypothesis that GDNF is
involved in tumoural germ cell proliferation. To this end,
we took advantage of TCam-2 cells, a seminoma cell line.
First, expression of GDNF co-receptors was analysed by
RT-PCR analysis (Fig. 2A) and by IHC (Fig. 2B). GFRA1 is
alternatively spliced into two highly homologous isoforms,
GFRA1a and GFRA1b, which differ at five amino acids
(Shefelbine et al., 1998). Both GFRA1 isoforms are
expressed in the TCam-2 cells (Fig. 2A). Ret undergoes
alternative splicing, which generates the Ret9 and Ret51
isoforms, differing at the carboxyl-termini (Arighi et al.,
2005). As observed by RT-PCR analysis, both Ret9 and
Ret51 transcripts are present in the TCam-2 cells (Fig. 2A).
GFRA1, but not RET, was detected by IHC (Fig. 2B). We
next addressed whether GDNF modulates TCam-2 prolifer-
ation or survival. Serum-starved cells were treated in the
absence and in the presence of 100 ng ⁄mL GDNF with or
without 10% FBS for 24, 48 and 72 h. The total number of
cells, as well as the number of dead cells, did not vary in
GDNF-treated cells compared with the control at each time
point analysed (Figure S2). FACS analysis was performed
to determine the percentage of TCam-2 cells in S phase
(Figure S3). Although FBS significantly increased the per-
centage of cells in S phase compared with the control,
GDNF did not induce S-phase entry of TCam-2 cells at any
time points analysed (Figure S3).
GDNF induces TCam-2 cell migration
In other cellular systems, GDNF has been implicated in
the migration and invasion of normal and tumour cells
GDNF-induced invasion in seminoma cells F. Ferranti et al.
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Figure 1 Immunohistochemical detection of GDNF co-receptors in seminoma samples. Images are from six representative seminoma tissue
samples. (A) GFRA1 cellular localization: (i) seminiferous tubules with preserved spermatogenesis adjacent to CIS lesion. GFRA1 expression was
detected in Leydig cells (asterisks) and in the basal compartment of seminiferous tubules where subsets of dark and pale type A spermatogonia
were positive (arrows); (ii) seminiferous tubules with CIS cells showing high GFRA1 staining (arrows). CIS cells were recognized morphologically or
with anti-c-Kit immunodetection on serial sections (not shown); (iii) GFRA1-positive intratubular seminoma cells (asterisk). GFRA1 expression was
up-regulated in seminoma cells compared with spermatogonia (arrows) in adjacent seminiferous tubules with preserved spermatogenesis (star);
(iv) c-Kit (CD117) and (v) GFRA1 immunostaining in adjacent sections of the same seminoma tissue sample. Note the fibrous septa rich in infiltrat-
ing inflammatory cells (arrows); (vi) high magnification of GFRA1-positive invasive seminoma cells (arrows), infiltrating lymphocytes are negative
(asterisks). (B) Ret cellular localization: (i) lack of Ret staining in preserved testicular parenchyma Ret of seminiferous tubules both in germ and
somatic cells, while Ret-positive cells (possibly Leydig cells) are detected in the interstitial compartment (asterisk). Dark type A spermatogonia are
indicated by arrows, and a Sertoli cell nucleus is indicated by an arrowhead; (ii) high Ret cytoplasmic staining was detected in Sertoli cells (stars)
present in seminiferous tubules containing Ret-negative CIS cells (arrows); (iii) in some seminiferous tubules, clusters of Ret-positive Sertoli cells
were found sloughing into the lumen (asterisk). Arrowhead points to a Ret-positive Sertoli cell properly arranged in the epithelium. Arrows indi-
cate the same CIS cell identified on adjacent sections, which is Ret-negative and GFRA1-positive (inset). An asterisk indicates the same cluster of
Sertoli cells shown in (iii); (iv) in invasive seminoma cells, no Ret expression was detected. Arrows point to fibrous septa containing Ret-positive
cells; (v) Ret expression was detected in endothelial cells (arrows) lining the lumen of vessels. Endothelial cells show a morphological activated
phenotype with large euchromatic nuclei; and (vi) Ret staining was detected in clusters of possibly endothelial ⁄ pericyte precursors (arrows). Semi-
noma cells are Ret-negative (asterisks). No staining is present by omitting the primary antibodies as shown in insets presented in A (i, iv, v) and in
B (i, iv). Fig. A (i) and B (i) are from sample no. 10; Fig. A (iv-vi) and B (iv) are from sample no. 07; Fig. A (ii) is from sample no. 05. Fig. A (iii) is
from sample no. 06. Fig. B (iii), (v) and (vi) are from sample no. 08. Fig. B (ii) is from sample no. 02. Bars, 50 lm.
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(Tang et al., 1998; Okada et al., 1999; Young et al., 2001;
Veit et al., 2004; Paratcha et al., 2006; Song & Moon,
2006; Su et al., 2009). More interestingly, we recently
found that in vitro GDNF is a chemoattractant for mur-
ine undifferentiated spermatogonia (Dovere. L, unpublis-
hed data). Based on these observations, we tested the
hypothesis that the GDNF pathway could be involved in
TCam-2 seminoma cell migration using Boyden chamber
assays with increasing concentrations of GDNF (20–
150 ng ⁄mL). A significant effect on cell migration was
achieved with 100 and 150 ng ⁄mL GDNF (Fig. 3A). This
effect was blocked by an anti-hGDNF neutralizing anti-
body but not by the antibody isotype control (Fig. 3B).
When GDNF was added to both the upper and lower
chambers, and therefore no chemokine gradient was pres-
ent in the Boyden chamber, cell migration was decreased
to the control level (Fig. 3B). Chemoattractant activity of
1% FBS was comparable with 100 ng ⁄mL GDNF, and no
synergic effect was found when the TCam-2 cells were
stimulated with both 1% FBS and 100 ng ⁄mL GDNF
(Fig. 3B). Invasive migration of the TCam-2 seminoma
cell line is stimulated by the chemokine CXCL12, which
activates the ERK pathway (Gilbert et al., 2009). By com-
paring the GDNF chemoattractant activity with that of
CXCL12, we found that GDNF is more effective (approxi-
mately 50%) than CXCL12 (Fig. 3C). In addition to the
observation that GDNF is an in vitro chemoattractant for
undifferentiated mouse spermatogonia (Dovere. L, unpub-
lished data), these data suggest that the chemoattractant
activity of GDNF is conserved in both normal and trans-
formed germ cells. We next investigated the GDNF-trig-
gered pathway involved in TCam-2 migration. In different
tumour cell types, GDNF activates the MEK and PI3K
pathways (Veit et al., 2004; Song & Moon, 2006; Su et al.,
2009). Three different inhibitors were tested as follows: PP-
2 (a potent Src-inhibitor), LY294002 (a PI3K-inhibitor)
and U0126 (a MEK-inhibitor). PP-2 (Fig. 4A) and UO126
(Fig. 4B), but not LY294002 (Fig. 4C), completely abol-
ished GDNF-induced cell migration. These data suggest
that GDNF-induced migration is mediated by the Src and
MEK pathways but not by the PI3K pathway.
GDNF promotes TCam-2 cell invasion in a
protease-dependent fashion
We next addressed whether invasion could be triggered
by GDNF in TCam-2 cells. Invasion was analysed at 24
and 48 h using a modified Boyden chamber assay with
Matrigel-coated filters. At both time points, GDNF
administration significantly enhanced the invasion of cells
compared with the control, as well as with CXCL12
(Fig. 5A). Tumour cell invasion can occur through two
modalities: a proteolytic mesenchymal-like or non-proteo-
lytic amoeboid-like modality (Sahai & Marshall, 2003;
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Figure 2 Identification of GDNF co-receptor variants expressed in TCam-2 cells. (A) RT-PCR analysis. Total RNA was prepared from TCam-2 cells
and used as a template for RT-PCR analysis. A sample containing RNA from human brain and a sample containing no reverse transcriptase were
used, respectively, as positive and negative controls. A b-actin primer set was used as a loading control. (B) Immunohistochemical detection of
GDNF co-receptors in TCam-2 cells: (i) GFRA1 and (ii) Ret. No staining is present by omitting the primary antibodies (inset). Bars, 20 lm.
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Wolf et al., 2003). The mesenchymal-like strategy of inva-
sion requires extracellular matrix degradation by prote-
ases, including MMPs, and thus, it is sensitive to protease
inhibitors. In contrast, the amoeboid-type modality is
protease-independent, with cells that adopt a rounded
morphology. To identify which of the two modalities is
employed by the TCam-2 cells in GDNF-induced cell
invasion, we tested a cocktail of protease inhibitors
(named prot. inh. mix), which included GM6001 (a
broad MMPs inhibitor), E64 (targets cysteine proteases
such as cathepsins B, L, H and K), pepstatin A (inhibits
aspartic proteases including cathepsin D), leupeptin (a
broad inhibitor of cysteine proteases and cathepsin D)
and aprotinin (an inhibitor of serine proteases, such as
urokinase and tissue plasminogen activator) (Carragher
et al., 2006). Prot. inh. mix administration completely
abolished the GDNF-induced TCam-2 cell invasion
(Fig. 5B), suggesting a protease-dependent invasion strat-
egy. To evaluate the contribution of MMPs to TCam-2
cell invasion, the MMPs-specific inhibitor GM6001 was
tested alone, and its activity was compared with prot. inh.
mix without GM6001. GM6001 alone, but not the other
inhibitors, reduced the GDNF-induced TCam-2 cells
invasion, suggesting the involvement of MMPs (Fig. 5B).
MMP-2 and MMP-9 activity (Fig. 5C) was detected in
TCam-2 cell extracts and conditioned medium by gelatin
zymography.
Discussion
In recent years, evidence has emerged showing the impor-
tance of GDNF for proper spermatogenesis. In mice,
GDNF is secreted by Sertoli cells and promotes spermato-
gonial stem cell self-renewal (Hofmann, 2008). Over-
expression of GDNF in adult transgenic mice induces
proliferation of clusters of undifferentiated spermatogonia
within seminiferous tubules (Meng et al., 2000). In addi-
tion, older animals develop testicular tumours that mimic
human seminoma, suggesting that over-activation of this
pathway may lead to the development of germ cell
tumours (Meng et al., 2001). Supporting this hypothesis,
Ret, a co-receptor for GDNF, is a well-known oncogene
that upon mutation and ⁄or rearrangement undergoes
constitutive GDNF- and GFRA1-independent activation.
Activating mutations of Ret were previously reported in
several types of cancer, including thyroid, pituitary, adre-
nal and melanoma cancer. However, human seminoma
does not appear to be linked to mutations or relevant
polymorphisms of Ret (Chevalier et al., 2010). An alterna-
tive mechanism for driving germ cell tumour progression
could be the up-regulation of wild-type GFRA1 and ⁄or
Ret proteins. Over-expression of GFRA1 and ⁄or Ret has
been found in different cancers (Takaya et al., 1996; Daw-
son et al., 1998; Nakashima et al., 2007), and in some
instances, Ret over-expression correlates with poor sur-
vival (Ito et al., 2005) as well as the development of a
subgroup of breast tumours (Esseghir et al., 2007). We
demonstrate, for the first time, that GFRA1 is up-regu-
lated in CIS, and its expression is maintained in invasive
seminoma. However, Ret was not detected by IHC in
normal germ cells, in CIS cells, or in the invasive semino-
ma. In TCam-2 cells, Ret was detected at mRNA but not
protein levels, suggesting that in CIS and seminoma cells,
Ret protein may be expressed at very low levels. Alterna-
tively, GFRA1 may transduce GDNF signal in a Ret-inde-
pendent fashion (Airaksinen & Saarma, 2002; Sariola &
Saarma, 2003). To date, a number of CIS and seminoma
cells markers are known to be expressed in foetal gono-
A
B
C
Figure 3 GDNF-dependent migration of TCam-2 cells. Cell migration
was evaluated using the Boyden chamber assay as detailed in the
Materials and Methods section. (A) TCam-2 cells were treated with
increasing concentrations of GDNF. (B) TCam-2 cells were treated as
indicated at final concentrations of 100 ng ⁄ mL GDNF, 15 lg ⁄mL anti-
GDNF antibody, 15 lg ⁄ mL control-IgG or foetal bovine serum (FBS)
(1% v ⁄ v). To abrogate the GDNF gradient in the Boyden chamber,
100 ng ⁄ mL GDNF was added both in the upper and lower chamber.
(C) TCam-2 cells were treated with 100 ng ⁄ mL GDNF or with increas-
ing concentrations of CXCL12 (SDF-1). Data are expressed as the
mean ± SEM (n = 3, measured in triplicate). *p < 0.001 vs. control
(one-way ANOVA, Dunnet post hoc).
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cytes but not in adult spermatogonia. However, CIS cells
also express genes found in the germ cells of normal adult
testis (i.e. VASA, TSPY, DAZ and DAZL) (Rajpert-De
Meyts, 2006). Because GFRA1 is detected in dark and pale
type A spermatogonia, GFRA1 lengthens the list of
tumour germ cell markers that are expressed in normal
germ cells.
To elucidate the biological activity of GDNF in semi-
noma, we employed the TCam-2 cell line as an experi-
mental model system. Even though TCam-2 cells express
the GDNF co-receptors, GDNF did not affect cell
survival and proliferation. Because GDNF acts as a
chemoattractant in several normal and tumour cell types
(Tang et al., 1998; Okada et al., 1999; Young et al., 2001;
Veit et al., 2004; Paratcha et al., 2006; Song & Moon,
2006; Su et al., 2009), we tested the hypothesis that
GDNF is a chemoattractant for the TCam-2 seminoma
cell line. GDNF induced TCam-2 cell migration and was
mediated by the Src and MEK pathways. In contrast,
PI3K does not seem to be involved in GDNF-induced
migration. Our findings are consistent with the observa-
tion that in some pancreatic carcinoma cells, GDNF is
not mitogenic but acts as a chemoattractant (Veit et al.,
2004). We found that GDNF induces TCam-2 cell inva-
sion through GFR-Matrigel, a matrix consisting of lami-
nin, collagen, entactin and growth factors. Invasive
tumour dissemination involves proteolytic degradation
and remodelling of the extracellular matrix (ECM) barri-
ers, a process dependent upon extracellular proteases,
including MMPs (Kessenbrock et al., 2010). However,
protease inhibition does not completely abolish tumour
cell migration and dissemination, suggesting alternative
compensating protease-independent mechanisms (Zucker
et al., 2000; Coussens et al., 2002). Of note, when prote-
olysis is blocked, some tumour cell types switch from a
protease-dependent mesenchymal type of motility to an
amoeboid-like rounded mode of motility that requires
Rho ⁄ROCK signalling (Sahai & Marshall, 2003; Wolf
et al., 2003). By using inhibitors of a wide range of peri-
cellular proteases, we found that the invasive strategy
used by TCam-2 cells is protease-dependent, which sug-
gests a mesenchymal-like invasion. Among candidate
proteases implicated in GDNF-induced TCam-2 cell
invasion are the MMPs, the most prominent family of
proteases involved in tumourigenesis (Kessenbrock et al.,
2010). The lack of invasion upon inhibition of pericellu-
lar proteases suggest that TCam-2 cells are not able to
undergo the mesenchymal-ameboid switch, thus suggest-
ing a lack of plasticity compared with more aggressive
tumour cell types (Carragher et al., 2006).
We demonstrated that GFRA1 expression is up-regu-
lated in CIS and seminoma cells. This raises the question
as to the source of GDNF in seminoma. In normal
human testis, GDNF is produced by the Sertoli and peri-
tubular cells, which form the wall of the seminiferous
tubules (Spinnler et al., 2010). The expression level of
GDNF was found to be similar in peritubular cells
isolated from patients suffering from azoospermia and
fibrotic remodelling of the peritubular wall (Spinnler
et al., 2010). At present, data are not available regarding
the expression level and regulation of GDNF in normal
human testis or those affected by pathological conditions,
including TGCTs. However, our preliminary results indi-
cate that GDNF mRNA levels are heterogeneous in nor-
mal testis and seminoma samples. In infertile mouse
A
B
C
Figure 4 The effect of different inhibitors on GDNF-induced TCam-2
cell migration. Cell migration was evaluated using the Boyden cham-
ber assay as detailed in the Materials and Methods section. TCam-2
cells were pre-treated for 30 min with 10 lm PP-2 (A), 10 lm U0126
(B) or an indicated concentration of LY294002 (C) followed by stimu-
lation with 100 ng ⁄ mL GDNF. In the control samples, DMSO was
added to the highest concentration present in the treated samples.
The results are expressed as the mean ± SEM, (n = 3, measured in
triplicate). *p < 0.001 vs. control (one-way ANOVA, Dunnet post hoc).
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models, GDNF levels are inversely correlated with the
germ cell content of the testis, possibly through the regu-
lation of the hypothalamus–pituitary axis (Tadokoro
et al., 2002). Moreover, GDNF expression in Sertoli cells
is induced by inflammatory cytokines (Simon et al.,
2007). Therefore, it could be speculated that, as described
in some breast cancers (Esseghir et al., 2007), local levels
of GDNF in the tumour microenvironment may be
increased as a consequence of leucocyte infiltration
and ⁄or spermatogenic arrest, which are commonly found
in TGCTs. Although currently it is not possible to directly
address whether CIS and intratubular seminoma cells
respond to local GDNF by increasing their ability to
migrate and invade the interstitial compartment, our
combined in vivo and in vitro observations suggests that
GDNF may induce tumour cell migration and dissemina-
tion within the testis. Recently, it has been suggested that
the expression level of the chemokine CXCL12 (SDF-1)
in TGCT samples is a predictive marker of relapse for
patients affected by a subset of type II TGCTs, that is,
stage I non-seminoma. Patients with moderate to strong
expression of CXCL12 have a reduced risk of relapse, sug-
gesting that a high level of chemokines in the tumour
microenvironment may impact tumour germ cell spread-
ing and metastatic potential (Gilbert et al., 2009). Follow-
ing this line of reasoning, it would be interesting to assess
whether or not the expression level of GDNF signalling
pathway molecules have a similar prognostic value in
patients affected by seminoma tumours.
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Supporting Information
Additional Supporting Information may be found in the online version
of this article:
Figure S1. Immunohistochemical analysis performed on adjacent paraffin
sections obtained from sample no. 7. GFRA1 antibodies identify CIS and
seminoma cells similar to two routinely used diagnostic markers, such as
c-Kit antibodies (CD117) and PLAP. Anti-CD34 antibodies detect endo-
thelial cells. Inset represent a negative control. Bars, 100 lm.
Figure S2. GDNF is not a mitogenic factor for TCam-2 cells. (A) TCam-
2 cells were serum-starved for 16 h and then cultured in the presence or
absence of 100 ng ⁄mL GDNF with or without 10% FBS for 24, 48 and
72 h. Percentage of dead cells at each time point is shown in (B). The
results are from a representative of three experiments performed. Data
are shown as the mean ± SEM of triplicate samples.
Figure S3. GDNF does not induce S-phase entry in TCam-2 cells. (A)
Flow cytometry analysis reveals that TCam-2 cells have a tetraploid DNA
content. LYMPHO: human lymphocytes. (B) Cell cycle phase distribution
of TCam-2 cells treated in the absence or presence of 100 ng ⁄mL GDNF
or with 10% FBS (as a positive control) for 12, 24 and 48 h of culture.
Percentage of cells in G1, G2 and S phase for each experimental condi-
tion is presented in (C). The results are from a representative of three
experiments performed. *p < 0.05 (one-way anova, Dunnet post hoc).
Table S1. List of primers used in RT-PCR analysis.
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